Pharmanutra Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	138.01	131.69	115.5	100.2	82.72	68.11
Other Revenue	0.72	0.47	0.65	0.5	0.34	0.03
Revenue	138.73	132.16	116.15	100.71	83.06	68.14
Revenue Growth (YoY)	16.65%	13.78%	15.33%	21.24%	21.89%	20.04%
Cost of Revenue	67.97	65.37	56.91	52.09	41.14	35.99
Gross Profit	70.76	66.79	59.24	48.62	41.92	32.15
Selling, General & Admin	35.36	32.71	26.67	22.55	17.19	12.12
Other Operating Expenses	1.46	1.41	1.81	0.43	0.34	0.34
Operating Expenses	40.48	37.69	31.88	25.6	18.84	13.86
Operating Income	30.29	29.1	27.36	23.02	23.07	18.3
Interest Expense	-0.75	-0.66	-1.06	-0.8	-0.06	-0.02
Interest & Investment Income	0.64	0.52	0.68	0.32	0.13	0.15
Currency Exchange Gain (Loss)	-0.08	-0.08	-0.04	0.08	-0.03	-
Other Non Operating Income (Expenses)	1.64	1.64	0.77	1.17	0.34	0.4
EBT Excluding Unusual Items	31.73	30.52	27.71	23.79	23.45	18.83
Gain (Loss) on Sale of Assets	-0	-0	-0.27	-0.03	-0.03	-0.02
Legal Settlements	-0.33	-0.33	-0.27	-0.5	-	-
Pretax Income	31.4	30.19	27.16	23.26	23.42	18.81
Income Tax Expense	10.45	10.27	10.61	10.43	8.37	5.04
Earnings From Continuing Operations	20.94	19.92	16.55	12.83	15.05	13.77
Minority Interest in Earnings	0.08	0.09	0.06	-	-	-
Net Income	21.02	20	16.61	12.83	15.05	13.77
Net Income to Common	21.02	20	16.61	12.83	15.05	13.77
Net Income Growth	28.07%	20.44%	29.43%	-14.73%	9.27%	-2.14%
Shares Outstanding (Basic)	10	10	10	10	10	10
Shares Outstanding (Diluted)	10	10	10	10	10	10
Shares Change (YoY)	-0.60%	-0.16%	-0.67%	-0.05%	-0.09%	-
EPS (Basic)	2.20	2.09	1.73	1.33	1.56	1.42
EPS (Diluted)	2.20	2.09	1.73	1.33	1.56	1.42
EPS Growth	28.84%	20.63%	30.29%	-14.69%	9.37%	-2.13%
Free Cash Flow	16.07	16.43	16.17	-1.16	-8.69	15.43
Free Cash Flow Per Share	1.68	1.71	1.68	-0.12	-0.90	1.59
Dividend Per Share	-	1.200	1.000	0.850	0.800	0.710
Dividend Growth	-	20.00%	17.65%	6.25%	12.68%	5.97%
Gross Margin	51.01%	50.54%	51.00%	48.28%	50.47%	47.18%
Operating Margin	21.83%	22.02%	23.55%	22.86%	27.78%	26.85%
Profit Margin	15.15%	15.14%	14.30%	12.74%	18.12%	20.21%
Free Cash Flow Margin	11.58%	12.43%	13.92%	-1.15%	-10.46%	22.64%
EBITDA	33.09	31.82	30.87	25.44	24.22	19.3
EBITDA Margin	23.85%	24.08%	26.58%	25.26%	29.16%	28.33%
D&A For EBITDA	2.81	2.72	3.51	2.42	1.15	1.01
EBIT	30.29	29.1	27.36	23.02	23.07	18.3
EBIT Margin	21.83%	22.02%	23.55%	22.86%	27.78%	26.85%
Effective Tax Rate	33.30%	34.03%	39.06%	44.83%	35.74%	26.78%
Revenue as Reported	140.54	133.97	116.91	101.96	83.39	68.84

Source: S&P Global Market Intelligence. Standard template. Financial Sources.